GlassScriptPhysician profile
Justin W Birkner
NPI 1164989075
$7,740.06
in general payments reported to CMS, 2019-2025
33 companies · $1,901 in 2025
The $1,901 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,023 · 2022: $678 · 2023: $1,473 · 2024: $2,665 · 2025: $1,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,345 · Travel and Lodging: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,345.15 |
| Travel and Lodging | $693.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,324.45 | 2021-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $639.58 | 2021-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $584.14 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $559.73 | 2022-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $544.17 | 2021-2023 | Xiaflex, Aveed, Edex |
| Teleflex LLC | $531.07 | 2021-2025 | Urolift |
| Medtronic, INC. | $497.26 | 2021-2025 | Interstim |
| Sumitomo Pharma America, INC. | $425.79 | 2023-2025 | Gemtesa |
| Pfizer INC. | $342.17 | 2022-2025 | |
| Endo USA, INC. | $287.29 | 2024-2025 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $263.82 | 2022-2025 | |
| Abc Home Medical Supply, INC. | $252.44 | 2022-2025 | |
| Tolmar, INC. | $196.11 | 2023-2025 | Eligard, Jatenzo |
| Janssen Biotech, INC. | $160.32 | 2022-2025 | Erleada |
| Boston Scientific Corporation | $145.02 | 2022-2023 | Rezum Generator |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $96.40 | 2025 | |
| Merck Sharp & Dohme LLC | $90.38 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Convatec INC. | $84.91 | 2023 | |
| Allergan, INC. | $82.27 | 2021-2022 | |
| Myovant Sciences INC. | $81.06 | 2021-2022 | |
| Antares Pharma, INC. | $72.01 | 2025 | Xyosted |
| Ambu INC. | $59.32 | 2021-2025 | |
| Procept Biorobotics Corporation | $57.24 | 2024 | Aquabeam System |
| Acerus Pharmaceuticals Corporation | $56.87 | 2021 | |
| Verity Pharmaceuticals INC. | $52.49 | 2025 | Trelstar |
| Olympus America INC. | $46.44 | 2024-2025 | Itind System |
| 180 Medical, INC. | $38.11 | 2023-2024 | Gentlecath |
| Urovant Sciences INC | $37.67 | 2021-2022 | |
| Telix Pharmaceuticals | $36.88 | 2025 | Illuccix |
| Immunitybio, INC. | $30.86 | 2025 | |
| Biotissue Holdings INC. | $28.92 | 2021 | |
| Coloplast Corp | $17.73 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $17.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Birkner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.